These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9051188)

  • 1. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
    Talve LA; Collan YU; Ekfors TO
    J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact.
    Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
    Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric, DNA and PCNA in thin malignant melanomas.
    Björnhagen V; Månsson-Brahme E; Lindholm J; Mattsson A; Auer G
    Med Oncol Tumor Pharmacother; 1993; 10(3):87-94. PubMed ID: 7903405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleaching of melanin before image cytometry of the DNA content of pigmented skin tumors.
    Talve LA; Collan YU; Alanen KA
    Anal Quant Cytol Histol; 1995 Oct; 17(5):344-50. PubMed ID: 8534337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the nuclear deoxyribonucleic acid content and nuclear morphometry in 71 primary cutaneous melanomas.
    Renard N; Goldschmidt D; Decaestecker C; Lorea P; Berthe JV; Verraes S; Ghanem G; Salmon I; Kiss R
    Dermatology; 1997; 194(4):318-24. PubMed ID: 9252750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
    Talve L; Kainu J; Collan Y; Ekfors T
    Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters and expression of tumor suppressor proteins (p53 and p16(INK4a)) and bcl-2 oncoprotein.
    Mijovic Z; Kostov M; Mihailovic D; Zivkovic N; Stojanovic M; Zdravkovic M
    J BUON; 2013; 18(2):471-6. PubMed ID: 23818364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of DNA flow cytometry and image cytometry on effusion fluid.
    Saha I; Dey P; Vhora H; Nijhawan R
    Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
    Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
    Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.